Tamoxifen is an anticancer drug that induces oxidative stress and apoptosis via mitochondria-dependent and nitric oxide (NO)-dependent pathways. The present report shows that tamoxifen increases intramitochondrial ionized Ca 2+ concentration and stimulates mitochondrial NO synthase (mtNOS) activity in the mitochondria from rat liver and human breast cancer MCF-7 cells. By stimulating mtNOS, tamoxifen hampers mitochondrial respiration, releases cytochrome c, elevates mitochondrial lipid peroxidation, increases protein tyrosine nitration of certain mitochondrial proteins, decreases the catalytic activity of succinyl-CoA:3-oxoacid CoA-transferase, and induces aggregation of mitochondria. The present report suggests a critical role for mtNOS in apoptosis induced by tamoxifen. [Cancer Res 2007;67(3):1282-90] 
Introduction
Tamoxifen is a cancer chemotherapeutic agent of a drug family known as estrogen receptor (ER) modulators. Tamoxifen exerts ER antagonistic and agonistic properties in various cells and tissues (1) (2) (3) . Many cancer chemotherapeutic agents (4), including tamoxifen (5), exert their anticancer properties by inducing apoptosis through mechanisms that involve mitochondria. Therapeutic doses of tamoxifen are 150 to 300 Ag d À1 kg À1 body weight with an average therapeutic blood concentration of 120 ng/mL that is equal to 0.3 Amol/L (6). Treatment of isolated rat liver mitochondria with 20 to 100 Amol/L tamoxifen, concentrations 60 to 300 times greater than the therapeutic, inhibited mitochondrial permeability transition pore opening (7) . Likewise, these high concentrations of tamoxifen increased the mitochondrial respiration and proton permeability and decreased mitochondrial transmembrane potential (Dw) and oxidative phosphorylation (8, 9) , typifying uncoupling mitochondria. The present study tested the effect of submicromolar concentrations of tamoxifen on mitochondria.
Tamoxifen induces apoptosis in both ER-positive and ERnegative cells via nitric oxide (NO)-dependent pathways (10) . Tamoxifen increased the NO synthase (NOS) activity in 10T1/2 murine fibroblasts (11) and in human erythroleukemia K562 cells undergoing apoptosis induced by tamoxifen (10) . Moreover, exogenously added NO-potentiated tamoxifen-induced apoptosis and inhibition of NOS activity prevented the apoptosis induced by tamoxifen (10) . We have shown that mitochondria possess a NOS [mitochondrial NOS (mtNOS)] that generates NO in response to elevation of intramitochondrial ionized Ca 2+ concentration ([Ca 2+ ] m ; refs. 12, 13) . NO generated by mtNOS regulates mitochondrial bioenergetics via reversible regulation of cytochrome oxidase activity (12, 13) . mtNOS-derived NO also generates peroxynitrite that induces oxidative stress and apoptosis (13) . The present study investigated the function of mtNOS for oxidative stress and apoptosis induced by tamoxifen. It was found that tamoxifen increases [Ca 2+ ] m that stimulates mtNOS activity of isolated rat liver mitochondria and human breast cancer MCF-7 cells. It was found that tamoxifen also induces oxidative stress and release of cytochrome c from mitochondria by mechanisms resembling mtNOS-derived peroxynitrite formation.
Materials and Methods
Mitochondria and mitochondrial subfraction preparations. Liver mitochondria were purified from female Sprague-Dawley rats as described (14) . The purity of the mitochondria was verified by measuring the cytochrome a content at 605 to 630 nm using the extinction coefficient of 12 mmol/L À1 cm À1 (14) . Only mitochondria with <5% impurity were used in this study. Broken mitochondria were prepared from freshly isolated intact mitochondria by freeze-thawing followed by hypoosmolar shock as described (12, 14) . Mitochondria and cytoplasm of MCF-7 cells were isolated as described (15) . Briefly, after washing cells twice in PBS, protease inhibitor cocktail [aprotinin, pepstatin A, phenylmethylsulfonyl fluoride (PMSF), and leupeptin (10 Amol/L each); refs. 13, 15] was added and cells were homogenized with 20 to 30 strokes with a glass homogenizer while visualizing microscopically to avoid overhomogenizing that damages the mitochondria. The homogenate was centrifuged at 1,000 Â g and the pellet was discarded. The supernatant was centrifuged at 10,000 Â g for 30 min and the crude cytoplasmic (supernatant) and mitochondrial (pellet) fractions were separated. The crude cytoplasmic fraction was centrifuged at 100,000 Â g and the cytoplasm (supernatant) was collected. Mitochondria were purified from crude mitochondria fraction by 20% Percoll purification at 100,000 Â g followed by rinsing twice in cold buffer.
Incubation procedure for liver mitochondria. Unless mentioned otherwise, intact or broken mitochondria [1 mg protein in 100 AL HEPES buffer (100 mmol/L; pH 7.10)] were incubated with 100 Amol/L N N -monomethyl-L-arginine (L-NMMA; to inhibit mtNOS; ref. 14) or 100 Amol/L glutathione monoethyl ester (GME; to supplement mitochondria with glutathione; ref. 16 ) for 30 min on ice. After this incubation time, tamoxifen (0.1 or 0.5 Amol/L) or equal volume of its solvent (ethanol) was added and mitochondria were incubated for 20 min at room temperature with occasional gentle shaking. When used, horse heart cytochrome c (680 pmol; ref. 17 ) was added immediately before tamoxifen.
Incubation procedure for MCF-7 cells. Cells were cultured in phenol red-free DMEM. At 80% confluence, cells were passaged using 5% trypsin and 0.03% EDTA and seeded at 1 Â 10 6 cells/mL. At f80% confluence, cells were treated with tamoxifen (0.1-10 Amol/L; ref. 18) in the absence or presence of L-nitroarginine methyl ester (L-NAME; 100 Amol/L; NOS inhibitor) for 12 to 72 h.
Mitochondrial oxygen consumption. Liver mitochondria samples were suspended in a final volume of 1 mL HEPES buffer, respiration was supported by K + -succinate (0.8 mmol/L), and the oxygen consumption was determined using a Clark-type oxygen electrode (Harvard Apparatus, Holliston, MA) as described (14) .
NOS activity. NOS activity was determined by citrulline assay, NO-sensitive electrode (World Precision Instrument, Sarasota, FL; Apollo 4000), and NO chemiluminescence analyzer (Sievers 280i, General Electric, Boulder, CO) as described (14) . For citrulline assay, liver mitochondria were incubated as under incubation procedure for liver mitochondria, whereas buffer was supplemented with 30,000 to 50,000 cpm L-[ 3 H]arginine. At the end of the incubation, mtNOS activity was terminated by adding ice-chilled stop solution [2 mmol/L EDTA and 1 mmol/L unlabeled L-citrulline in 20 mmol/L Na + -acetate buffer (pH 5.00)]. Samples were run through Dowex columns prepared as described (14) , and mtNOS activity was determined by measuring the radioactivity of the effluent. To measure mtNOS activity with the NO electrode, 1 mg broken mitochondria incubated as under incubation procedure for liver mitochondria were added to the HEPES buffer (1,000 AL final volume) and NO formation was detected with a NO-sensitive electrode (amiNO 100, Innovative Instruments, Tampa, FL) using a 7-Am tip. Tamoxifen, L-NMMA, or EGTA at the concentrations used in this study did not interfere with the signal detected by the NO electrode. To measure NOS activity in MCF-7 cells, their cytoplasm or mitochondria, samples were injected into the purge vessel containing vanadium chloride (0.8% in 1 mol/L HCl) thermostated at 95jC and the chemiluminescence of the NO released was measured using the NO analyzer (Sievers 280i). The vessel was depleted of oxygen by purging with N 2 at least 20 min before injecting the samples and during the entire measurement. NaNO 2 was used to prepare the standard curve.
[ ] m was also measured in broken mitochondria. No cccp or AA was added to the broken mitochondria preparation. Standard curves were obtained by using known concentrations of Ca 2+ added to the broken mitochondria suspensions. Tamoxifen or L-NMMA at the concentrations used in this study did not interfere with the Ca 2+ signal detected by either method.
Both [Ca 2+ ] m detection assays are very sensitive; however, they require larger amounts of mitochondria than can be obtained from cultured cells. Therefore, the Ca 2+ fluorescent probe fura-2 was used and a series of experiments was conducted to establish a sensitive assay to measure [Ca 2+ ] m in very small amounts of mitochondria. Fura-2 (the active form) in the absence or presence of Ca 2+ was excited from 320 to 400 nm and emission was collected at 510 nm using an Aminco DW-2000 dual-beam dual-wavelength spectrophotometer equipped with original Aminco fluorescent unit. A clear peak and a sharp isosbestic point were detected at 352 and 362 nm, respectively. Next, isolated mitochondria were loaded with the membrane-permeable fura-2/acetoxymethylester ( fura-2/AM; 15 min followed by twice wash in cold buffer), excited from 320 to 400 nm, and emission was collected at 510 nm. Identical peak and isosbestic point of 352 and 362 nm were detected. To do a highly sensitive [Ca 2+ ] m measurement, fura-2-loaded mitochondria were excited at dual wavelengths of peak minus isosbestic point (352-362 nm) and emission was detected at 510 nm. Mitochondrial #y. The Dw of intact liver mitochondria was supported by K + -succinate (800 Amol/L) and measured at 511 to 533 nm in the presence of 10 Amol/L safranin as described (13, 17) .
Cytochrome c release and lipid peroxidation. Cytochrome c was determined by Western blot using monoclonal anti-cytochrome c antibody (eBioscience, San Diego, CA) as described (13, 17) . Lipid peroxidation (LPO) was determined by measuring thiobarbituric acid-reactive substances (TBARS) at 535 nm as described (13) .
Protein tyrosine nitration. Samples were lysed in 100 AL lyses buffer containing 133 mmol/L NaCl, 50 mmol/L Tris-HCl (pH 8.00), 0.1% SDS, 0.5% sodium deoxycholate, 0.1% NP40, and protease inhibitors (10 Amol/L each): PMSF, pepstatin A, leupeptin, and aprotinin. Proteins (20 Ag) of each sample were separated by SDS-PAGE on a 10% gel and blotted onto nitrocellulose membrane, probed with monoclonal anti-nitrotyrosine antibody (Alexis Biochemicals, San Diego, CA) or monoclonal anti-cytochrome oxidase subunit VIc antibody (Molecular Probes, Eugene, OR) as loading control, and visualized with alkaline phosphatase.
Activity of succinyl-CoA:3-oxoacid CoA-transferase. Liver mitochondria samples were thrice frozen-thawed in liquid nitrogen followed by addition of ice-cold H 2 O ( four times the volume of mitochondria suspension) containing protease inhibitors (leupeptin, aprotinin, pepstatin-A, and PMSF; 10 Amol/L each) to fully rupture mitochondrial membranes (14) . The suspension was centrifuged at 100,000 Â g at 4jC for 30 min and the supernatant [soluble fraction (SF)] was collected. One Mitochondria aggregation. Aggregation of liver mitochondria was studied as described (24) by using a light microscope (BalPlanBausch&Lomb, Rochester, NY) connected to a digital camera (Nikon Coolpix 4500, Nikon, Koga Ku, Japan). Mitochondria samples (3 Ag mitochondrial protein/AL) were placed on a Petroff-Hausser counting chamber with 20 Am cell depth (Hausser Scientific, Horsham, PA). Tamoxifen (0.1 and 0.5 Amol/L) or its solvent (control) was added and microphotographs were taken in triplicate every 5 min.
Results and Discussion
Apoptosis is a fundamental mechanism that regulates cell and tissue homeostasis and eliminates cancer cells (25) . It is generally believed that insufficient apoptosis causes cancer (26) . Many cancer chemotherapeutic agents (4), including tamoxifen (5, 27), induce oxidative stress and apoptosis via mechanisms that involve mitochondria and NO (10, 11) . We (12) and several other laboratories (refs. 27-31; reviewed in ref. 32 ) have shown that mitochondria generate NO through the Ca 2+ -sensitive mtNOS. Stimulation of mtNOS leads to formation of peroxynitrite that induces oxidative stress (33) and mitochondrial apoptosis (13) . The present study investigated the function of mtNOS for tamoxifeninduced oxidative stress and apoptosis.
Tamoxifen increases mtNOS activity, decreases mitochondrial oxygen consumption, and increases [Ca 2+ ] m . Figure 1A shows that submicromolar concentrations of tamoxifen increased mtNOS activity of intact isolated rat liver mitochondria and that this effect of tamoxifen was prevented with L-NMMA. Figure 1B shows that NO formation by broken mitochondria was increased by tamoxifen and that this effect of tamoxifen was prevented when mtNOS was inhibited with L-NMMA, or [Ca 2+ ] m was removed by EGTA. An L-NMMA-and EGTA-sensitive increase in NO formation of broken mitochondria was also observed for 0. (12, 13) . Thus, the present study tested the effect of tamoxifen on mitochondrial oxygen consumption. Figure 1C shows that tamoxifen decreased the oxygen consumption of intact liver mitochondria. Some studies suggested that tamoxifen increased the oxygen consumption of mitochondria (7) (8) (9) . This can be explained by considering that those studies used 20 to 100 Amol/L tamoxifen, which is 60 to 300 times >0.3 Amol/L, the submicromolar concentration of tamoxifen (6) . Tamoxifen is highly lipophilic and high concentrations of lipophilic compounds readily increase mitochondrial respiration by perturbing the mitochondrial membrane integrity and uncoupling the mitochondria. Figure 1C shows that the decrease of mitochondrial oxygen consumption was prevented when mtNOS was inhibited by L-NMMA. This finding indicates that tamoxifen decreased the mitochondrial oxygen consumption by stimulating mtNOS activity. Figure 1C shows that tamoxifen also decreased the respiration of broken mitochondria and that this effect of tamoxifen was prevented when [Ca 2+ ] m was chelated by EGTA. This finding together with those presented in (12, 19) . To rule out possible direct effect of tamoxifen on Ca 2+ transport system of intact mitochondria, the effect of tamoxifen on broken mitochondria was tested. Figure 2B shows that tamoxifen increased the Ca 2+ concentration in broken mitochondria and that L-NMMA did not alter this effect of tamoxifen. Elevation of [Ca 2+ ] m neutralizes the negative charges of the inner mitochondrial membrane and decreases the Dw. Thus, the present study tested the effect of tamoxifen on Dw. Figure 2C shows that tamoxifen decreased the Dw and that this effect of tamoxifen was prevented when [Ca 2+ ] m was chelated by EGTA. This finding further supports the findings presented in Fig 2A and B and (21, 22) . fura-2 (the active form) in the absence (no Ca 2+ ) or presence of Ca 2+ (1-50 Amol/L) was excited and emission was collected at 510 nm (35) , and a clear peak and a sharp isosbestic point were detected at 352 and 362 nm, respectively (Fig. 3A) . Next, liver mitochondria were loaded with membrane-permeable fura-2AM, excited, and emission was collected at 510 nm. Identical peak and isosbestic points of 352 and 362 nm were detected (Fig. 3B) (Fig. 3C ). No autofluorescence was observed when mitochondria not loaded with fura-2 were excited in the absence or presence of 1 to 10 Amol/L Ca 2+ (data not shown). Figure 3C also shows that the Scheme. Mitochondria, mtNOS, and tamoxifen. Mitochondria consist of the inner (IM ) and the outer membrane (OM ), matrix, and the intermembrane space (IMS ). The respiratory chain consists of four complexes (I-IV), coenzyme Q (Q; ubiquinone), and ATP synthase also called complex V, which are embedded in the IM.
Electrons (e À ) flow down the chain to complex IV and reduce O 2 to H 2 O. Coupled to the electron flow, protons (H + ) are pumped from the matrix into the IMS. The proton extrusion establishes a transmembrane potential (Dw ; negative inside) and an electrochemical gradient (DpH; alkaline inside) across the coupling membrane. The Dw is the driving force for mitochondria to take up Ca 2+ . Fig. 3 . Figure  3A and B where single-wavelength excitation spectra were used have same scales that are different from those used in Fig. 3C and D where excitation was done at dual wavelengths of 352À362 nm. As shown, 5 Amol/L Ca 2+ caused an increase in fluorescence of f0.1 unit on Fig. 3B, whereas 4 Amol/L Ca 2+ generated an increase in fluorescence of f1 unit in Fig. 3C , indicating at least one order of magnitude increased sensitivity when dual-wavelength excitation was used. The scale of Fig. 3C is different from Fig. 3D because 1 mg rat liver mitochondria was used in Fig. 3C, whereas Fig. 3D  used 10 Ag mitochondria of human epithelial breast cancer cells.
Mitochondria take up and accommodate large amounts of calcium very rapidly; however, [Ca 2+ ] m is maintained very low by precipitating the [Ca 2+ ] m to the matrix electron-dense granules C, MCF-7 cells were treated with tamoxifen (3 Amol/L 48 h) in the absence or presence of L-NAME as in Fig. 1E . LPO was measured in the cytoplasm (white columns ) or mitochondria (black columns ) and expressed as picomolar TBARS per milligram protein. Columns, mean of four experiments; bars, SE. *, P < 0.05; **, P < 0.01, significantly different from control. Within the mitochondria, mtNOS-derived NO use up to 15% of the entire O 2 À generated by the mitochondrial inner membrane (33) and produces peroxynitrite (13, 30, 31, 42) with the extremely rapid rate of 9.5 Â 10 À8 mol/L s À1 (33) . Results presented in this study indicate that tamoxifen increases mitochondrial NO formation. Thus, it was tested whether tamoxifen increases mitochondrial peroxynitrite.
Tamoxifen releases cytochrome c and elevates LPO. Release of cytochrome c from the mitochondria is one of the key events during most forms of apoptosis, including that induced by tamoxifen (43) . Stimulation of mtNOS increases mitochondrial peroxynitrite that releases cytochrome c from the mitochondria (13) . mtNOS stimulation also increases LPO that is a widely used peroxynitrite biomarker (13, 44) . Figure 4A and B shows that tamoxifen released cytochrome c from liver mitochondria and increased LPO and that those effects of tamoxifen were prevented when mtNOS was inhibited. These findings suggest that tamoxifen released the cytochrome c and elevated LPO by stimulating mtNOS. To test whether these effects of tamoxifen were mediated by peroxynitrite, mitochondria were supplemented with glutathione. Supplementing mitochondria with glutathione prevented the apoptosis induced by tamoxifen (45) and decreased the oxidative damage induced by peroxynitrite (46) (47) (48) . Elegant work of Nakamura et al. (46) has shown that glutathione reverses the peroxynitrite-induced oxidative damage by converting peroxynitrite to S-nitrosating species (47) . Figure 4A and B shows that supplementing mitochondria with glutathione prevented tamoxifen-induced release of cytochrome c and increase of LPO. Supplementing cells with cytochrome c prevents apoptosis induced by tamoxifen (45) and supplementing mitochondria with cytochrome c prevents elevated LPO induced by mtNOS-derived peroxynitrite (13) . Figure 4B shows that supplementing mitochondria with cytochrome c prevented tamoxifen-induced LPO elevation. These findings strongly suggest that tamoxifen increases peroxynitrite in liver mitochondria.
The present study also tested whether tamoxifen elevates LPO in MCF-7 cells. Figure 4C shows that whereas tamoxifen did not increase LPO in the cytoplasm of MCF-7 cells, there was a substantial increase in LPO of mitochondria of MCF-7 cells. Tamoxifen-induced increase in mitochondrial LPO was fully abolished when MCF-7 cells were treated with a NOS inhibitor. These findings strongly suggest that tamoxifen increases peroxynitrite in the mitochondria of MCF-7 cells.
Tamoxifen increases protein tyrosine nitration and decreases SCOT activity. Peroxynitrite readily reacts with tyrosine residues to produce nitrotyrosine. Determination of protein tyrosine nitration has been widely used as a reliable peroxynitrite biomarker (49) . Figure 5A shows that tamoxifen increased the tyrosine nitration of certain liver mitochondrial proteins and that this effect of tamoxifen was prevented when mtNOS was inhibited. This finding further suggest that tamoxifen increases mitochondrial peroxynitrite via stimulating mtNOS. Figure 5A shows substantial increase in the tyrosine nitration of a protein with molecular weight of f50 kDa. SCOT is a 52-kDa mitochondrial matrix protein that is involved in energy production in malignant cells (50) and undergoes peroxynitrite-induced tyrosine nitration (23) . Figure 5B shows that tamoxifen decreased the activity of SCOT and that this effect of tamoxifen was prevented when mtNOS was inhibited. This finding suggests that the 50-kDa tyrosine-nitrated protein shown in Fig. 5A is SCOT. Figure 5A and B also shows that supplementing mitochondria with glutathione or cytochrome c prevented tamoxifen-induced increase in protein tyrosine nitration and decrease in the SCOT activity, which confirms the results presented in Fig. 4A and B and further indicate tamoxifen increases mitochondrial peroxynitrite.
Tamoxifen induces aggregation of mitochondria. Mitochondrial movement and morphology alter under different conditions (51) . During early stages of apoptosis, mitochondria form aggregates, and mitochondrial aggregation precedes the release of cytochrome c (52). It has been shown that peroxynitrite causes mitochondrial aggregation followed by release of cytochrome c (53). Because the results presented thus far strongly suggest that tamoxifen increases mtNOS-derived peroxynitrite formation, the present study tested whether tamoxifen induces mitochondrial aggregation. Figure 6 shows that tamoxifen induced extensive aggregation of isolated liver mitochondria and that this effect of tamoxifen was prevented when mtNOS was inhibited or when were supplemented with glutathione. These novel findings suggest that tamoxifen-induced mitochondrial aggregation was mediated by mtNOS-derived peroxynitrite. Figure 6 also shows that supplementing mitochondria with cytochrome c prevented mitochondrial aggregation. This finding confirms the previous reports (27, 52, 53) and further suggests that the release of cytochrome c precedes the aggregation of mitochondria.
Taken together, the present study shows that submicromolar concentrations of tamoxifen stimulate mtNOS activity by elevating [Ca 2+ ] m (Scheme). Tamoxifen-induced mtNOS stimulation increases mitochondrial peroxynitrite, which causes oxidative and nitrative stress. NO generated in the cytoplasm exerts antiapoptotic properties by mechanisms involving caspase S-nitrosation, whereas NO produced within the mitochondria becomes proapoptotic by generating peroxynitrite (42) . Findings presented in the present study strongly suggest that tamoxifen increases mitochondrial peroxynitrite.
These findings suggest a pivotal role for mtNOS in oxidative stress and apoptosis induced by tamoxifen and propose a novel mechanism for the action of a widely used cancer chemotherapeutic agent.
